UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (6277) 6277
humans (5960) 5960
life sciences & biomedicine (5954) 5954
antineoplastic agents, phytogenic - pharmacology (3329) 3329
animals (3223) 3223
female (3037) 3037
male (2721) 2721
oncology (2522) 2522
antineoplastic agents, phytogenic - administration & dosage (2324) 2324
antineoplastic agents, phytogenic - therapeutic use (2237) 2237
pharmacology & pharmacy (2075) 2075
mice (1821) 1821
cell line, tumor (1760) 1760
cancer (1631) 1631
middle aged (1528) 1528
aged (1262) 1262
antineoplastic agents, phytogenic - pharmacokinetics (1219) 1219
adult (1212) 1212
apoptosis - drug effects (1172) 1172
apoptosis (1133) 1133
paclitaxel (1035) 1035
antineoplastic agents, phytogenic - chemistry (1032) 1032
antineoplastic agents, phytogenic - adverse effects (1024) 1024
chemotherapy (1024) 1024
paclitaxel - administration & dosage (907) 907
dose-response relationship, drug (881) 881
cell proliferation - drug effects (846) 846
camptothecin - analogs & derivatives (775) 775
treatment outcome (758) 758
care and treatment (727) 727
chemistry (724) 724
physical sciences (724) 724
neoplasms - drug therapy (713) 713
rats (704) 704
analysis (689) 689
research (671) 671
plant extracts - pharmacology (668) 668
cell survival - drug effects (651) 651
biochemistry & molecular biology (648) 648
tumors (602) 602
paclitaxel - therapeutic use (598) 598
chemistry, medicinal (566) 566
paclitaxel - pharmacology (561) 561
antineoplastic combined chemotherapy protocols - therapeutic use (547) 547
breast neoplasms - drug therapy (532) 532
breast cancer (526) 526
medicine & public health (526) 526
mice, nude (525) 525
health aspects (517) 517
antineoplastic agents (487) 487
antineoplastic agents, phytogenic - blood (462) 462
xenograft model antitumor assays (461) 461
mice, inbred balb c (460) 460
paclitaxel - pharmacokinetics (454) 454
antimitotic agents (448) 448
antineoplastic agents, phytogenic - isolation & purification (445) 445
pharmacology/toxicology (445) 445
chemistry, multidisciplinary (435) 435
phytotherapy (432) 432
drug delivery systems (418) 418
lung neoplasms - drug therapy (411) 411
cytotoxicity (408) 408
time factors (408) 408
pharmacokinetics (398) 398
drug therapy (393) 393
tumor cells, cultured (392) 392
drug administration schedule (386) 386
cell biology (385) 385
camptothecin - administration & dosage (379) 379
metastasis (377) 377
irinotecan (362) 362
antineoplastic agents, phytogenic - toxicity (359) 359
hematology (359) 359
paclitaxel - adverse effects (357) 357
cancer therapies (335) 335
rats, sprague-dawley (335) 335
cell cycle (333) 333
breast neoplasms - pathology (332) 332
proteins (331) 331
signal transduction - drug effects (329) 329
aged, 80 and over (323) 323
research article (322) 322
camptothecin - pharmacokinetics (318) 318
plant extracts - therapeutic use (317) 317
drug resistance, neoplasm (316) 316
administration, oral (311) 311
medicine (311) 311
abridged index medicus (309) 309
integrative & complementary medicine (309) 309
nanoparticles (308) 308
drugs (298) 298
drug screening assays, antitumor (297) 297
infusions, intravenous (296) 296
etoposide - administration & dosage (292) 292
biomedicine (290) 290
plant extracts - chemistry (290) 290
cancer research (288) 288
science & technology - other topics (279) 279
survival analysis (274) 274
area under curve (273) 273
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7280) 7280
Japanese (112) 112
Chinese (95) 95
German (22) 22
Russian (16) 16
French (13) 13
Portuguese (7) 7
Spanish (5) 5
Italian (3) 3
Croatian (2) 2
Hungarian (2) 2
Dutch (1) 1
Hebrew (1) 1
Norwegian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Pharmaceutical research, ISSN 0724-8741, 6/2015, Volume 32, Issue 6, pp. 1947 - 1956
Irinotecan (IRI) is a broad spectrum chemotherapeutic agent used individually or in combination to treat multiple malignancies... 
Biochemistry, general | Biomedical Engineering | self-assembly | polypeptide | Biomedicine | irinotecan | Pharmacy | block ionomer complex | Medical Law | Pharmacology/Toxicology | anticancer | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Neoplasms - metabolism | Camptothecin - chemistry | Humans | Polyethylene Glycols - chemistry | Drug Carriers | Dose-Response Relationship, Drug | Nanoparticles | Antineoplastic Agents, Phytogenic - administration & dosage | Micelles | Camptothecin - blood | Camptothecin - administration & dosage | Antineoplastic Agents, Phytogenic - pharmacokinetics | Antineoplastic Agents, Phytogenic - blood | Camptothecin - analogs & derivatives | Camptothecin - pharmacokinetics | Cell Survival - drug effects | Solubility | Antineoplastic Agents, Phytogenic - chemistry | Technology, Pharmaceutical - methods | Chemistry, Pharmaceutical | Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Animals | Tumor Burden - drug effects | Mice, Nude | Cell Line, Tumor | Mice, Inbred BALB C | Antineoplastic Agents, Phytogenic - pharmacology | Neoplasms - pathology | Camptothecin - pharmacology | Ethylene glycol | Chemotherapy | Analysis | Drugstores | Aspartate | Cancer | Drug delivery systems | Pharmacology | Polypeptides | Index Medicus
Journal Article
Cancer chemotherapy and pharmacology, ISSN 1432-0843, 05/2013, Volume 72, Issue 1, pp. 139 - 146
Journal Article
Cancer chemotherapy and pharmacology, ISSN 0344-5704, 8/2011, Volume 68, Issue 2, pp. 445 - 455
The natural flavonoid fisetin was recently identified as a lead compound that stabilizes endothelial cell microtubules. In this study, we investigated the... 
Fisetin | Lewis lung carcinoma | Angiogenesis | Antitumour activity | Cyclophosphamide | Medicine & Public Health | Cancer Research | Oncology | Cytotoxicity | EA·hy 926 endothelial cells | Pharmacology/Toxicology | Flavonoid | EA•hy 926 endothelial cells | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | NIH 3T3 Cells | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Tubulin Modulators - pharmacology | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents, Alkylating - pharmacology | Flavonoids - adverse effects | Antineoplastic Agents, Alkylating - administration & dosage | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Flavonoids - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Angiogenesis Inhibitors - administration & dosage | Antineoplastic Agents, Phytogenic - administration & dosage | Angiogenesis Inhibitors - therapeutic use | Flavonoids - administration & dosage | Tubulin Modulators - administration & dosage | Female | Flavonoids - pharmacology | Antineoplastic Agents, Phytogenic - therapeutic use | Angiogenesis Inhibitors - adverse effects | Antineoplastic Agents, Phytogenic - adverse effects | Cell Line | Cell Survival - drug effects | Tubulin Modulators - adverse effects | Mice, Inbred C57BL | Angiogenesis Inhibitors - pharmacology | Tubulin Modulators - therapeutic use | Carcinoma, Lewis Lung - drug therapy | Antineoplastic Agents, Alkylating - therapeutic use | Cell Movement - drug effects | Animals | Tumor Burden - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Endothelial Cells - cytology | Neovascularization, Pathologic - drug therapy | Cyclophosphamide - pharmacology | Carcinoma, Lewis Lung - pathology | Cell Proliferation - drug effects | Mice | Antineoplastic Agents, Alkylating - adverse effects | Antineoplastic Agents, Phytogenic - pharmacology | Cell Cycle - drug effects | Endothelial Cells - drug effects | Antimitotic agents | Flavonoids | Flavones | Lung cancer | Bioflavonoids | Accountants | Drug therapy, Combination | Universities and colleges | Antineoplastic agents | Endothelium | Tumors | Index Medicus | cytology | Antineoplastic Agents, Phytogenic | pathology | Cell Proliferation | Endothelial Cells | Tubulin Modulators | Neovascularization, Pathologic | fisetin | administration & dosage | pharmacology | flavonoid | Carcinoma, Lewis Lung | Antineoplastic Agents, Alkylating | cytotoxicity | drug therapy | Cell Survival | angiogenesis | Antineoplastic Combined Chemotherapy Protocols | drug effects | Tumor Burden | Angiogenesis Inhibitors | EA.hy 926 | Cell Cycle | antitumour activity | adverse effects | therapeutic use | Cell Movement
Journal Article
Pharmaceutical research, ISSN 0724-8741, 3/2015, Volume 32, Issue 3, pp. 1028 - 1044
Determine the feasibility and potential benefit of peripherally cross-linking the shell of core-shell polymer micelles on the premature release of physically loaded hydrophobic drug in whole blood... 
Biochemistry, general | poloxamer 407 | drug delivery | Biomedical Engineering | vascular disrupting agents | Biomedicine | pluronic F127 | Pharmacy | peripheral shell cross-linking | Medical Law | Pharmacology/Toxicology | polymer nanocarriers | premature drug release | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Stilbenes - administration & dosage | Humans | Stilbenes - chemistry | Breast Neoplasms - metabolism | Drug Carriers | Feasibility Studies | Dose-Response Relationship, Drug | Antineoplastic Agents, Phytogenic - administration & dosage | Micelles | Female | Antineoplastic Agents, Phytogenic - pharmacokinetics | Antineoplastic Agents, Phytogenic - blood | Poloxamer - chemistry | Cross-Linking Reagents - chemistry | Human Umbilical Vein Endothelial Cells - drug effects | Ethylenediamines - chemistry | Cells, Cultured | Solubility | Antineoplastic Agents, Phytogenic - chemistry | Technology, Pharmaceutical - methods | Breast Neoplasms - drug therapy | Chemistry, Pharmaceutical | Administration, Intravenous | Animals | Breast Neoplasms - pathology | Cell Line, Tumor | Hydrophobic and Hydrophilic Interactions | Stilbenes - pharmacokinetics | Human Umbilical Vein Endothelial Cells - pathology | Mice | Mice, Inbred BALB C | Stilbenes - blood | Drugs | Phosphates | Antimitotic agents | Drug delivery systems | Breast cancer | Polymer industry | Polymers | Antineoplastic agents | Ethylenediamines | Vehicles | Pharmaceutical sciences | Cancer | Index Medicus | Pluronic F127
Journal Article
British journal of clinical pharmacology, ISSN 0306-5251, 02/2016, Volume 81, Issue 2, pp. 313 - 315
Journal Article